Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Case You Missed It: Top 10 Gray Sheet Stories In March

This article was originally published in The Gray Sheet

Executive Summary

A story covering the latest details on FDA's Office of Regulatory Affairs wholesale restructuring was the most popular Gray Sheet item last month, followed by a piece with tips on regaining FDA's trust. There was also significant interest in our coverage of the closely watched Vascular Solutions off-label case, challenges for notified bodies in Europe, Senate action, user-fee negotiations, and more.


Related Content

Shuren In The Lion’s Den: Device Center Chief Defends LDT Plan At Clinical Lab Meeting, Fields Wide Array Of Questions
Senate Panel Passes Breakthrough Device, Other Measures; FDA Funding Debated
Vascular Solutions Not-Guilty Verdict Another Challenge To FDA Off-Label Oversight


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts